The most common cabozantinib-associated adverse events (all grades) included diarrhea (63.1%), palmar-plantar erythrodysesthesia (50%), decreased weight (47.7%), decreased appetite (45.8%), nausea (43%), and fatigue (40.7%) Grade 3 or 4 adverse events were reported in 69% of patients in the cabozantinib group and 33% of patients in the placebo group
0.6% (4/663), respectively
Ozempic does not directly rot the gallbladder, but it can slow gallbladder contractions, which may increase the risk of gallstone formation
When considering Ozempic for weight loss or diabetes management, understanding its safety profile and potential risks is crucial for patients
Luke explains, that may trigger early onset male or female pattern hair loss